Mechanisms, consequences, and prevention of coronary graft failure

Circulation

Volumn 136, Issue 18, 2017, Pages 1749-1764

  Gaudino, Mario ^a   Antoniades, Charalambos ^b   Benedetto, Umberto ^c   Deb, Saswata ^d   Di Franco, Antonino ^a   Di Giammarco, Gabriele ^e   Fremes, Stephen ^d   Glineur, David ^f   Grau, Juan ^f   He, Guo Wei ^g   Marinelli, Daniele ^e   Ohmes, Lucas B ^a   Patrono, Carlo ^h   Puskas, John ⁱ   Tranbaugh, Robert ^a   Girardi, Leonard N ^a   Taggart, David P ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CHIETI   (Italy)

^f UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^g PEKING UNION MEDICAL COLLEGE   (China)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CABG; Graft failure; Myocardial revascularization

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; EDIFOLIGIDE;

AGE; ARTERY GRAFT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY GRAFT FAILURE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GRAFT FAILURE; GRAFT PATENCY; HUMAN; HYPERTENSION; INTERNAL THORACIC ARTERY GRAFT; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIAL ARTERY GRAFT; RIGHT GASTROEPIPLOIC ARTERY GRAFT; RISK ASSESSMENT; RISK FACTOR; SAPHENOUS VEIN GRAFT; SECONDARY PREVENTION; SEX DIFFERENCE; THROMBOSIS; VASOCONSTRICTION; VASOSPASM; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; GRAFT OCCLUSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY VESSELS; GRAFT OCCLUSION, VASCULAR; HUMANS; RISK FACTORS;

EID: 85032622701     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.027597     Document Type: Article

References (104)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626.
2. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE; RAPS Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012;60:28-35. doi: 10.1016/j.jacc.2012.03.037.
3. Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Califf RM, Kouchoukos N T, Peterson ED, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT I V. Circulation. 2014;130:1445-1451. doi: 10.1161/CIRCULATIONAHA.113.008193.
4. Cao C, Manganas C, Horton M, Bannon P, Munkholm-Larsen S, Ang SC, Yan TD. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2013;146:255-261. doi: 10.1016/j.jtcvs.2012.07.014.
5. Collins P, Webb CM, Chong CF, Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008;117:2859-2864. doi: 10.1161/CIRCULATIONAHA.107.736215.
6. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149-2156. doi: 10.1016/j.jacc.2004.08.064.
7. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916-931.
8. Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg. 2015;150:880-888. doi: 10.1016/j.jtcvs.2015.07.027.
9. Kim KB, Hwang HY, Hahn S, Kim JS, Oh SJ. A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: one-year angiographic results and mid-term clinical outcomes. J Thorac Cardiovasc Surg. 2014;148:901-907. doi: 10.1016/j.jtcvs.2014.03.057.
10. Meirson T, Orion E, Di Mario C, Webb C, Patel N, Channon KM, Ben Gal Y, Taggart D P. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg. 2015;150:871-878. doi: 10.1016/j.jtcvs.2015.04.061.
11. Tatoulis J, Buxton B F, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004;77:93-101.
12. Tatoulis J, Buxton B F, Fuller JA. The right internal thoracic artery: the forgotten conduit-5,766 patients and 991 angiograms. Ann Thorac Surg. 2011;92:9-15. doi: 10.1016/j.athoracsur.2011.03.099.
13. Achouh P, Acar C. Twenty-year fate of the radial artery graft. Ann Cardiothorac Surg. 2013;2:481-484. doi: 10.3978/j.issn.2225-319X.2013.07.13.
14. Gaudino M, Tondi P, Benedetto U, Milazzo V, Flore R, Glieca F, Ponziani FR, Luciani N, Girardi LN, Crea F, Massetti M. Radial artery as a coronary artery bypass conduit: 20-year results. J Am Coll Cardiol. 2016;68:603-610. doi: 10.1016/j.jacc.2016.05.062.
15. Buxton BF, Hayward PA, Matalanis G, Monten S, Horrigan M, Rosalion A. 10-year endpoint of RAPCO is reached: clinical and angiographic results of a randomised trial of radial artery versus right internal thoracic artery or saphenous vein for the second graft. Presented at the 96th annual meeting of the American Association for Thoracic Surgery, May 14-18, 2016, Baltimore, MD.
16. Deb S, Singh SK, Moussa F, Tsubota H, Une D, Kiss A, Tomlinson G, Afshar M, Sless R, Cohen EA, Radhakrishnan S, Dubbin J, Schwartz L, Fremes SE; Radial Artery Patency Study Investigators. The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: a substudy of the multicenter Radial Artery Patency Study. J Thorac Cardiovasc Surg. 2014;148:1246-1253. doi: 10.1016/j.jtcvs.2014.06.057.
17. Suzuki T, Asai T, Nota H, Kuroyanagi S, Kinoshita T, Takashima N, Hayakawa M. Early and long-term patency of in situ skeletonized gastroepiploic artery after off-pump coronary artery bypass graft surgery. Ann Thorac Surg. 2013;96:90-95. doi: 10.1016/j.athoracsur.2013.04.018.
18. Malvindi PG, Jacob S, Kallikourdis A, Vitale N. What is the patency of the gastroepiploic artery when used for coronary artery bypass grafting? Interact Cardiovasc Thorac Surg. 2007;6:397-402. doi: 10.1510/icvts.2007.155259.
19. Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257:824-833. doi: 10.1097/SLA.0b013e318288c38d.
20. Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, Virmani R. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016;13:79-98. doi: 10.1038/nrcardio.2015.164.
21. Walts AE, Fishbein MC, Matloff JM. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. Am Heart J. 1987;114(4 Pt 1):718-723.
22. Storey RF. Exploring mechanisms of graft occlusion toward improved outcomes in coronary artery bypass graft surgery. J Am Coll Cardiol. 2011;57:1078-1080. doi: 10.1016/j.jacc.2010.09.065.
23. Sabik JF 3rd. Understanding saphenous vein graft patency. Circulation. 2011;124:273-275. doi: 10.1161/CIRCULATIONAHA.111.039842.
24. Manchio JV, Gu J, Romar L, Brown J, Gammie J, Pierson RN 3rd, Griffith B, Poston RS. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. Ann Thorac Surg. 2005;79:1991-1998. doi: 10.1016/j.athoracsur.2004.12.054.
25. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg. 1995;59:676-683. doi: 10.1016/0003-4975(94)01011-0.
26. Tousoulis D, Antoniades C, Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart. 2005;91:553-558. doi: 10.1136/hrt.2003.032847.
27. Liu ZG, Ge ZD, He GW. Difference in endothelium-derived hyperpolarizing factor-mediated hyperpolarization and nitric oxide release between human internal mammary artery and saphenous vein. Circulation. 2000;102(19 Suppl 3):III296-III301.
28. He GW, Liu ZG. Comparison of nitric oxide release and endothelium-derived hyperpolarizing factor-mediated hyperpolarization between human radial and internal mammary arteries. Circulation. 2001;104(12 Suppl 1):I344-I349.
29. Antoniades C, Shirodaria C, Crabtree M, Rinze R, Alp N, Cunnington C, Diesch J, Tousoulis D, Stefanadis C, Leeson P, Ratnatunga C, Pillai R, Channon KM. Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation. 2007;116:2851-2859. doi: 10.1161/CIRCULATIONAHA.107.704155.
30. He GW, Angus JA, Rosenfeldt FL. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol. 1988;12:12-22.
31. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG, Ormont ML, Mannion JD, Zalewski A. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation. 2001;103:2408-2413.
32. Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem. 2012;19:2504-2520.
33. Atkinson JB, Forman MB, Vaughn WK, Robinowitz M, McAllister HA, Virmani R. Morphologic changes in long-term saphenous vein bypass grafts. Chest. 1985;88:341-348.
34. He GW. Arterial grafts: clinical classification and pharmacological management. Ann Cardiothorac Surg. 2013;2:507-518. doi: 10.3978/j.issn.2225-319X.2013.07.12.
35. Gluckman TJ, McLean RC, Schulman S P, Kickler TS, Shapiro EP, Conte JV, McNicholas KW, Segal JB, Rade JJ. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol. 2011;57:1069-1077. doi: 10.1016/j.jacc.2010.08.650.
36. Choudhary BP, Antoniades C, Brading AF, Galione A, Channon K, Taggart D P. Diabetes mellitus as a predictor for radial artery vasoreactivity in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2007;50:1047-1053. doi: 10.1016/j.jacc.2007.06.008.
37. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482-2494. doi: 10.1056/NEJMra071014.
38. Desai ND, Naylor CD, Kiss A, Cohen EA, Feder-Elituv R, Miwa S, Radhakrishnan S, Dubbin J, Schwartz L, Fremes SE; Radial Artery Patency Study Investigators. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation. 2007;115:684-691. doi: 10.1161/CIRCULATIONAHA.105.567495.
39. Shah PJ, Gordon I, Fuller J, Seevanayagam S, Rosalion A, Tatoulis J, Raman JS, Buxton B F. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg. 2003;126:1972-1977. doi: 10.1016/S0022.
40. Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Frequency and predictors of internal mammary artery graft failure and subsequent clinical outcomes: insights from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation. 2016;133:131-138. doi: 10.1161/CIRCU-LATIONAHA.115.015549.
41. Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, Goormastic M, Cosgrove DM. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1992;103:831-840.
42. Halabi AR, Alexander JH, Shaw LK, Lorenz TJ, Liao L, Kong DF, Milano CA, Harrington RA, Smith PK. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol. 2005;96:1254-1259. doi: 10.1016/j.amjcard.2005.06.067.
43. Lopes RD, Mehta RH, Hafley GE, Williams JB, Mack MJ, Peterson ED, Allen KB, Harrington RA, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, Alexander JH; Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125:749-756. doi: 10.1161/CIRCULATIONAHA.111.040311.
44. Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015;169:833-840. doi: 10.1016/j.ahj.2015.02.022.
45. Yamasaki M, Deb S, Tsubota H, Moussa F, Kiss A, Cohen EA, Radhakrishnan S, Dubbin J, Ko D, Schwartz L, Fremes SE; Radial Artery Patency Study Investigators. Comparison of radial artery and saphenous vein graft stenosis more than 5 years after coronary artery bypass grafting. Ann Thorac Surg. 2016;102:712-719. doi: 10.1016/j.athoracsur.2016.02.107.
46. Yoshizaki T, Tabuchi N, Toyama M. Verapamil and nitroglycerin improves the patency rate of radial artery grafts. Asian Cardiovasc Thorac Ann. 2008;16:396-400. doi: 10.1177/021849230801600511.
47. Gaudino M, Glieca F, Luciani N, Alessandrini F, Possati G. Clinical and angiographic effects of chronic calcium channel blocker therapy continued beyond frst postoperative year in patients with radial artery grafts: results of a prospective randomized investigation. Circulation. 2001;104(12 Suppl 1):I64-I67.
48. Wise ES, Hocking KM, Eagle S, Absi T, Komalavilas P, Cheung-Flynn J, Brophy CM. Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft. Surgery. 2015;158:537-546. doi: 10.1016/j.surg.2015.03.036.
49. Harskamp RE, Alexander JH, Schulte PJ, Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM, Kouchoukos NT, Harrington RA, Ferguson TB, Lopes RD. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014;149:798-805. doi: 10.1001/jamasurg.2014.87.
50. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446-2454.
51. Chello M, Mastroroberto P, Frati G, Patti G, D'Ambrosio A, Di Sciascio G, Covino E. Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft. Ann Thorac Surg. 2003;76:453-458.
52. Khaleel MS, Dorheim TA, Duryee MJ, Durbin HE Jr, Bussey WD, Garvin R P, Klassen LW, Thiele GM, Anderson DR. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Ann Thorac Surg. 2012;93:552-558. doi: 10.1016/j.athoracsur.2011.10.035.
53. Mounsey CA, Mawhinney JA, Werner RS, Taggart DP. Does previous transradial catheterization preclude use of the radial artery as a conduit in coronary artery bypass surgery? Circulation. 2016;134:681-688. doi: 10.1161/CIRCULATIONAHA.116.022992.
54. Zenati MA, Shroyer AL, Collins J F, Hattler B, Ota T, Almassi GH, Amidi M, Novitzky D, Grover FL, Sonel AF. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) trial. J Thorac Cardiovasc Surg. 2011;141:338-344. doi: 10.1016/j.jtcvs.2010.10.004.
55. Deppe AC, Liakopoulos OJ, Choi YH, Slottosch I, Kuhn EW, Scherner M, Stange S, Wahlers T. Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. J Surg Res. 2013;180:114-124. doi: 10.1016/j.jss.2012.11.013.
56. Sastry P, Rivinius R, Harvey R, Parker RA, Rahm AK, Thomas D, Nair S, Large SR. The influence of endoscopic vein harvesting on outcomes after coronary bypass grafting: a meta-analysis of 267,525 patients. Eur J Cardiothorac Surg. 2013;44:980-989. doi: 10.1093/ejcts/ezt121.
57. Rousou LJ, Taylor KB, Lu XG, Healey N, Crittenden MD, Khuri SF, Thatte HS. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Ann Thorac Surg. 2009;87:62-70. doi: 10.1016/j.athoracsur.2008.08.049.
58. Williams JB, Peterson ED, Brennan JM, Sedrakyan A, Tavris D, Alexander JH, Lopes RD, Dokholyan RS, Zhao Y, O'Brien SM, Michler RE, Thourani VH, Edwards FH, Duggirala H, Gross T, Marinac-Dabic D, Smith PK. Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308:475-484. doi: 10.1001/jama.2012.8363.
59. Sá MP, Ferraz PE, Escobar RR, Nunes EO, Lustosa P, Vasconcelos FP, Lima RC. Patency of skeletonized versus pedicled internal thoracic artery in coronary bypass graft surgery: a systematic review, meta-analysis and metaregression. Int J Surg. 2014;12:666-672. doi: 10.1016/j.ijsu.2014.05.071.
60. Gaudino M, Crea F, Cammertoni F, Mazza A, Toesca A, Massetti M. Technical issues in the use of the radial artery as a coronary artery bypass conduit. Ann Thorac Surg. 2014;98:2247-2254. doi: 10.1016/j.athoracsur.2014.07.039.
61. Shroyer AL, Grover FL, Hattler B, Collins J F, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D; Veterans Affairs Randomized On/Off Bypass (ROO-BY) Study Group. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361:1827-1837. doi: 10.1056/NEJMoa0902905.
62. Sousa Uva M, Cavaco S, Oliveira AG, Matias F, Silva C, Mesquita A, Aguiar P, Bau J, Pedro A, Magalhães MP. Early graft patency after off-pump and on-pump coronary bypass surgery: a prospective randomized study. Eur Heart J. 2010;31:2492-2499. doi: 10.1093/eurheartj/ehq210.
63. Puskas JD, Williams WH, O'Donnell R, Patterson RE, Sigman SR, Smith AS, Baio KT, Kilgo PD, Guyton RA. Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial. Ann Thorac Surg. 2011;91:1836-1842. doi: 10.1016/j.athoracsur.2010.12.043.
64. Kobayashi J, Tashiro T, Ochi M, Yaku H, Watanabe G, Satoh T, Tagusari O, Nakajima H, Kitamura S; Japanese Off-Pump Coronary Revascularization Investigation (JOCRI) Study Group. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation. 2005;112(9 Suppl):I338-I343. doi: 10.1161/CIRCULATIONAHA.104.524504.
65. Magee MJ, Alexander JH, Hafey G, Ferguson TB, Gibson CM, Harrington RA, Peterson ED, Califf RM, Kouchoukos NT, Herbert MA, Mack MJ; PREVENT IV Investigators. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. Ann Thorac Surg. 2008;85:494-499. doi: 10.1016/j.athoracsur.2007.10.008.
66. Deppe AC, Arbash W, Kuhn EW, Slottosch I, Scherner M, Liakopoulos OJ, Choi YH, Wahlers T. Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16,900 patients investigated in randomized controlled trials†. Eur J Cardiothorac Surg. 2016;49:1031-1041. doi: 10.1093/ejcts/ezv268.
67. Lamy A, Devereaux PJ, Prabhakaran D, Taggart D P, Hu S, Straka Z, Piegas LS, Avezum A, Akar AR, Lanas Zanetti F, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock R P, Ou Y, Gao P, Pettit S, Yusuf S; CORONARY Investigators. Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N Engl J Med. 2016;375:2359-2368. doi: 10.1056/NEJMoa1601564.
68. Diegeler A, Börgermann J, Kappert U, Breuer M, Böning A, Ursulescu A, Rastan A, Holzhey D, Treede H, Rieß FC, Veeckmann P, Asfoor A, Reents W, Zacher M, Hilker M; GOPCABE Study Group. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J Med. 2013;368:1189-1198. doi: 10.1056/NEJMoa1211666.
69. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6:16-26. doi: 10.1038/ncpcardio1397.
70. Suma H, Tanabe H, Takahashi A, Horii T, Isomura T, Hirose H, Amano A. Twenty years experience with the gastroepiploic artery graft for CABG. Circulation. 2007;116(11 Suppl):I188-I191. doi: 10.1161/CIRCULATIONAHA.106.678813.
71. Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, Bartunek J, Vanermen H, De Bruyne B. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004;110(11 Suppl 1):II36-II40. doi: 10.1161/01.CIR.0000141256.05740.69.
72. Honda K, Okamura Y, Nishimura Y, Uchita S, Yuzaki M, Kaneko M, Yamamoto N, Kubo T, Akasaka T. Graft flow assessment using a transit time flow meter in fractional flow reserve-guided coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2015;149:1622-1628. doi: 10.1016/j.jtcvs.2015.02.050.
73. Gaudino M, Alessandrini F, Nasso G, Bruno P, Manzoli A, Possati G. Severity of coronary artery stenosis at preoperative angiography and midterm mammary graft status. Ann Thorac Surg. 2002;74:119-121.
74. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka L F, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik J F, Selnes O, Shahian DM, Trost JC, Winniford MD. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e652-e735. doi: 10.1161/CIR.0b013e31823c074e.
75. Souza DS, Dashwood MR, Tsui JC, Filbey D, Bodin L, Johansson B, Borowiec J. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73:1189-1195.
76. Shiono Y, Kubo T, Honda K, Katayama Y, Aoki H, Satogami K, Kashiyama K, Taruya A, Nishiguchi T, Kuroi A, Orii M, Kameyama T, Yamano T, Yamaguchi T, Matsuo Y, Ino Y, Tanaka A, Hozumi T, Nishimura Y, Okamura Y, Akasaka T. Impact of functional focal versus diffuse coronary artery disease on bypass graft patency. Int J Cardiol. 2016;222:16-21. doi 10.1016/j.ijcard.2016.07.052.
77. Songur MÇ, Özyalçin S, Özen A, Şimşek E, Kervan Ü, Taçoǧlu İ, Kaplan S, Köse K, Ulus AT. Does really previous stenting affect graft patency following CABG? A 5-year follow-up: the effect of PCI on graft survival. Heart Vessels. 2016;31:457-464. doi:10.1007/s00380-015-0633-9
78. Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F-J, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541-2619 doi: 10.1093/eurheartj/ehu278
79. D'Ancona G, Karamanoukian HL, Ricci M, Schmid S, Bergsland J, Salerno TA. Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg. 2000;17:287-293
80. Gaudino M, Di Mauro M, Iacò AL, Canosa C, Vitolla G, Calafore AM. Immediate flow reserve of Y thoracic artery grafts: an intraoperative flowmetric study J Thorac Cardiovasc Surg. 2003;126:1076-1079. doi:10.1016/S0022
81. Kim KB, Kang CH, Lim C. Prediction of graft flow impairment by intraoperative transit time flow measurement in off-pump coronary artery bypass using arterial grafts. Ann Thorac Surg. 2005;80:594-598. doi:10.1016/jathoracsur.2005.02.047
82. Di Giammarco G, Pano M, Cirmeni S, Pelini P, Vitolla G, Di Mauro M. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg 2006;132:468-474. doi:10.1016/j.jtcvs.2006.02.014
83. Tokuda Y, Song MH, Oshima H, Usui A, Ueda Y. Predicting midterm coronary artery bypass graft failure by intraoperative transit time flow measurement. Ann Thorac Surg. 2008;86:532-536. doi:10.1016/j.athorac-sur.2008.04.023
84. Kieser TM, Rose S, Kowalewski R, Belenkie I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur J Cardiothorac Surg. 2010;38:155-162. doi 10.1016/j.ejcts.2010.01.026
85. Di Giammarco G, Canosa C, Foschi M, Rabozzi R, Marinelli D, Masuyama S, Ibrahim BM, Ranalletta RA, Penco M, Di Mauro M. Intraoperative graft verification in coronary surgery: increased diagnostic accuracy adding high-resolution epicardial ultrasonography to transit-time flow measurement. Eur J Cardiothorac Surg. 2014;45:e41-e45. doi:10.1093/ejcts/ezt580
86. Niclauss L. Techniques and standards in intraoperative graft verification by transit time flow measurement after coronary artery bypass graft surgery: a critical review. Eur J Cardiothorac Surg. 2017;51:26-33. doi:10.1093/ejcts/ezw203
87. Singh SK, Desai ND, Chikazawa G, Tsuneyoshi H, Vincent J, Zagorski BM, Pen V, Moussa F, Cohen GN, Christakis GT, Fremes SE. The Graft Imaging to Improve Patency (GRIIP) clinical trial results. J Thorac Cardiovasc Surg 2010;139:294-301. doi:10.1016/j.jtcvs.2009.09.048
88. Lehnert P, Møller CH, Damgaard S, Gerds TA, Steinbrüchel DA. Transittime flow measurement as a predictor of coronary bypass graft failure at one year angiographic follow-up. J Card Surg. 2015;30:47-52. doi 10.1111/jocs.12471
89. Kuroyanagi S, Asai T, Suzuki T. Intraoperative fluorescence imaging after transit-time flow measurement during coronary artery bypass grafting Innovations (Phila). 2012;7:435-440. doi:10.1097/IMI.0b013e318281260c
90. Possati G, Gaudino M, Alessandrini F, Zimarino M, Glieca F, Luciani N. Systematic clinical and angiographic follow-up of patients undergoing minimally invasive coronary artery bypass. J Thorac Cardiovasc Surg 1998;115:785-790. doi:10.1016/S0022-5223(98)70356-3
91. Kulik A, Ruel M, Jneid H, Ferguson TB, Hiratzka LF, Ikonomidis JS, Lopez-Jimenez F, McNallan SM, Patel M, Roger VL, Sellke FW, Sica DA, Zimmerman L; American Heart Association Council on Cardiovascular Surgery and Anesthesia. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association Circulation. 2015;131:927-964. doi:10.1161/CIR.0000000000000182
92. Hastings S, Myles P, McIlroy D. Aspirin and coronary artery surgery: a systematic review and meta-analysis. Br J Anaesth. 2015;115:376-385. doi 10.1093/bja/aev164
93. Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network. Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med. 2016;374:728-737. doi: 10.1056/NEJMoa1507688.
94. Patrono C. The multifaceted clinical readouts of platelet inhibition by low-dose aspirin. J Am Coll Cardiol. 2015;66:74-85. doi: 10.1016/j.jacc.2015.05.012.
95. Paikin JS, Hirsh J, Ginsberg JS, Weitz JI, Chan NC, Whitlock R P, Pare G, Johnston M, Eikelboom JW. Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial. J Thromb Haemost. 2015;13:448-456. doi: 10.1111/jth.12832.
96. Cavalca V, Rocca B, Veglia F, Petrucci G, Porro B, Myasoedova V, De Cristofaro R, Turnu L, Bonomi A, Songia P, Cavallotti L, Zanobini M, Carmera M, Alamanni F, Parolari A, Patrono C, Tremoli E. On-pump cardiac surgery enhances platelet renewal and impairs aspirin pharmaco-dynamics: effects of improved dosing regimens [published online ahead of print April 5, 2017]. Clin Pharmaco Ther. http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002/cpt.702.doi: 10.1002/cpt.702.
97. Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373-2383. doi: 10.1056/NEJMra052717.
98. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057. doi: 10.1056/NEJMoa0904327.
99. Held C, Asenblad N, Bassand J P, Becker RC, Cannon C P, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey R F, Vintila M, Ycas J, Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672-684. doi: 10.1016/j.jacc.2010.10.029.
100. Roffi M, Patrono C, Collet J P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew D P, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol Ç, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J; Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi: 10.1093/eurheartj/ehv320.
101. Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532-2561. doi: 10.1016/S0140-6736(16)31357-5.
102. Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153-162.
103. Yongxin S, Wenjun D, Qiang W, Yunqing S, Liming Z, Chunsheng W. Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits. Ann Thorac Surg. 2013;95:55-61. doi: 10.1016/j.athoracsur.2012.08.073.
104. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-1502. doi:10.1161/01.CIR.0000121747.71054.79.